Research ExplorerPublicationsA combination of galantamine and memantine modifies cognitiv...

A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.

Standard

A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. / Peters, O; Lorenz, D; Fesche, A; Schmidtke, K; Hüll, M; Perneczky, R; Rüther, E; Möller, H-J; Jessen, F; Maier, W; Kornhuber, J; Jahn, Holger; Luckhaus, C; Gertz, H-J; Schröder, J; Pantel, J; Teipel, S; Wellek, S; Frölich, L; Heuser, I.

In: J NUTR HEALTH AGING, Vol. 16, No. 6, 6, 2012, p. 544-548.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Peters, O, Lorenz, D, Fesche, A, Schmidtke, K, Hüll, M, Perneczky, R, Rüther, E, Möller, H-J, Jessen, F, Maier, W, Kornhuber, J, Jahn, H, Luckhaus, C, Gertz, H-J, Schröder, J, Pantel, J, Teipel, S, Wellek, S, Frölich, L & Heuser, I 2012, 'A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.', J NUTR HEALTH AGING, vol. 16, no. 6, 6, pp. 544-548. <http://www.ncbi.nlm.nih.gov/pubmed/22659994?dopt=Citation>

APA

Peters, O., Lorenz, D., Fesche, A., Schmidtke, K., Hüll, M., Perneczky, R., Rüther, E., Möller, H-J., Jessen, F., Maier, W., Kornhuber, J., Jahn, H., Luckhaus, C., Gertz, H-J., Schröder, J., Pantel, J., Teipel, S., Wellek, S., Frölich, L., & Heuser, I. (2012). A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J NUTR HEALTH AGING, 16(6), 544-548. [6]. http://www.ncbi.nlm.nih.gov/pubmed/22659994?dopt=Citation

Vancouver

Peters O, Lorenz D, Fesche A, Schmidtke K, Hüll M, Perneczky R et al. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J NUTR HEALTH AGING. 2012;16(6):544-548. 6.

Bibtex

@article{eff1b328ee8a4d7cbce54b37f5bd15b1,
title = "A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.",
abstract = "Mild cognitive impairment (MCI) is etiologically heterogeneous, and a substantial proportion of MCI subjects will develop different dementia disorders. One subtype of this syndrome, amnestic MCI, occurs preferentially but not exclusively in prodromal AD and is characterized by defined deficits of episodic memory.",
keywords = "Germany, Humans, Male, Aged, Female, Middle Aged, Psychiatric Status Rating Scales, Cohort Studies, Disease Progression, Double-Blind Method, Alzheimer Disease/physiopathology, Amnesia/etiology/*prevention & control, Cholinesterase Inhibitors/adverse effects/therapeutic use, Cognition/*drug effects, Dementia/prevention & control, Drug Therapy, Combination/adverse effects, Early Termination of Clinical Trials, Galantamine/adverse effects/*therapeutic use, Memantine/adverse effects/*therapeutic use, Mild Cognitive Impairment/*drug therapy/etiology/physiopathology, Nootropic Agents/adverse effects/*therapeutic use, Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors, Germany, Humans, Male, Aged, Female, Middle Aged, Psychiatric Status Rating Scales, Cohort Studies, Disease Progression, Double-Blind Method, Alzheimer Disease/physiopathology, Amnesia/etiology/*prevention & control, Cholinesterase Inhibitors/adverse effects/therapeutic use, Cognition/*drug effects, Dementia/prevention & control, Drug Therapy, Combination/adverse effects, Early Termination of Clinical Trials, Galantamine/adverse effects/*therapeutic use, Memantine/adverse effects/*therapeutic use, Mild Cognitive Impairment/*drug therapy/etiology/physiopathology, Nootropic Agents/adverse effects/*therapeutic use, Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors",
author = "O Peters and D Lorenz and A Fesche and K Schmidtke and M H{\"u}ll and R Perneczky and E R{\"u}ther and H-J M{\"o}ller and F Jessen and W Maier and J Kornhuber and Holger Jahn and C Luckhaus and H-J Gertz and J Schr{\"o}der and J Pantel and S Teipel and S Wellek and L Fr{\"o}lich and I Heuser",
year = "2012",
language = "English",
volume = "16",
pages = "544--548",
journal = "J NUTR HEALTH AGING",
issn = "1279-7707",
publisher = "Springer Paris",
number = "6",

}

RIS

TY - JOUR

T1 - A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.

AU - Peters, O

AU - Lorenz, D

AU - Fesche, A

AU - Schmidtke, K

AU - Hüll, M

AU - Perneczky, R

AU - Rüther, E

AU - Möller, H-J

AU - Jessen, F

AU - Maier, W

AU - Kornhuber, J

AU - Jahn, Holger

AU - Luckhaus, C

AU - Gertz, H-J

AU - Schröder, J

AU - Pantel, J

AU - Teipel, S

AU - Wellek, S

AU - Frölich, L

AU - Heuser, I

PY - 2012

Y1 - 2012

N2 - Mild cognitive impairment (MCI) is etiologically heterogeneous, and a substantial proportion of MCI subjects will develop different dementia disorders. One subtype of this syndrome, amnestic MCI, occurs preferentially but not exclusively in prodromal AD and is characterized by defined deficits of episodic memory.

AB - Mild cognitive impairment (MCI) is etiologically heterogeneous, and a substantial proportion of MCI subjects will develop different dementia disorders. One subtype of this syndrome, amnestic MCI, occurs preferentially but not exclusively in prodromal AD and is characterized by defined deficits of episodic memory.

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Psychiatric Status Rating Scales

KW - Cohort Studies

KW - Disease Progression

KW - Double-Blind Method

KW - Alzheimer Disease/physiopathology

KW - Amnesia/etiology/prevention & control

KW - Cholinesterase Inhibitors/adverse effects/therapeutic use

KW - Cognition/drug effects

KW - Dementia/prevention & control

KW - Drug Therapy, Combination/adverse effects

KW - Early Termination of Clinical Trials

KW - Galantamine/adverse effects/therapeutic use

KW - Memantine/adverse effects/therapeutic use

KW - Mild Cognitive Impairment/drug therapy/etiology/physiopathology

KW - Nootropic Agents/adverse effects/therapeutic use

KW - Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Psychiatric Status Rating Scales

KW - Cohort Studies

KW - Disease Progression

KW - Double-Blind Method

KW - Alzheimer Disease/physiopathology

KW - Amnesia/etiology/prevention & control

KW - Cholinesterase Inhibitors/adverse effects/therapeutic use

KW - Cognition/drug effects

KW - Dementia/prevention & control

KW - Drug Therapy, Combination/adverse effects

KW - Early Termination of Clinical Trials

KW - Galantamine/adverse effects/therapeutic use

KW - Memantine/adverse effects/therapeutic use

KW - Mild Cognitive Impairment/drug therapy/etiology/physiopathology

KW - Nootropic Agents/adverse effects/therapeutic use

KW - Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors

M3 - SCORING: Journal article

VL - 16

SP - 544

EP - 548

JO - J NUTR HEALTH AGING

JF - J NUTR HEALTH AGING

SN - 1279-7707

IS - 6

M1 - 6

ER -